Maria Planck
41 – 50 of 66
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Various Antibody Clones of Napsin A, Thyroid Transcription Factor 1, and p40 and Comparisons With Cytokeratin 5 and p63 in Histopathologic Diagnostics of Non-Small Cell Lung Carcinoma.
2015) In Applied Immunohistochemistry & Molecular Morphology(
- Contribution to journal › Article
- 2014
-
Mark
Lack of supportive evidence for the use of immunohistochemical staining to identify occult regional lymph node metastases in primary lung cancer.
(
- Contribution to journal › Article
-
Mark
Genomic and transcriptional alterations in lung adenocarcinoma in relation to smoking history.
(
- Contribution to journal › Article
-
Mark
Genome-wide DNA methylation analysis of lung carcinoma reveals one neuroendocrine and four adenocarcinoma epitypes associated with patient outcome.
(
- Contribution to journal › Article
- 2013
-
Mark
Genomic and Transcriptional Alterations in Lung Adenocarcinoma in Relation to EGFR and KRAS Mutation Status.
(
- Contribution to journal › Article
-
Mark
Histological specificity of alterations and expression of KIT and KITLG in non-small cell lung carcinoma.
(
- Contribution to journal › Article
-
Mark
Immunohistochemistry in the differential diagnostics of primary lung cancer: an investigation within the southern Swedish lung cancer study.
(
- Contribution to journal › Article
-
Mark
Identification of transcriptional subgroups in EGFR-mutated and EGFR/KRAS-wild type lung adenocarcinoma reveals gene signatures associated with patient outcome.
(
- Contribution to journal › Article
-
Mark
Detecting EGFR alterations in clinical specimens-pitfalls and necessities.
(
- Contribution to journal › Article
-
Mark
Landscape of somatic allelic imbalances and copy number alterations in human lung carcinoma.
(
- Contribution to journal › Article